LBIO (Longevity Biomedical) Current Ratio: 0.00 (As of . 20)


What is Longevity Biomedical Current Ratio?

Longevity Biomedical LBIO Current Ratio is 0.00 as of . 20.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Longevity Biomedical's current ratio for the quarter that ended in . 20 was 0.00.

Longevity Biomedical has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Longevity Biomedical has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Longevity Biomedical's Current Ratio or its related term are showing as below:

LBIO's Current Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.91
* Ranked among companies with meaningful Current Ratio only.

Longevity Biomedical  (NAS:LBIO) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.

Longevity Biomedical Current Ratio Related Terms

Longevity Biomedical Current Ratio Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Current Ratio Chart

Longevity Biomedical Annual Data
Trend
Current Ratio

Longevity Biomedical Semi-Annual Data
Current Ratio

LBIO vs : Current Ratio Comparison

For the Biotechnology subindustry, Longevity Biomedical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical Current Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Current Ratio distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Current Ratio falls into.


Longevity Biomedical Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Longevity Biomedical's Current Ratio for the fiscal year that ended in . 20 is calculated as

Current Ratio (A: . 20 )=Total Current Assets (A: . 20 )/Total Current Liabilities (A: . 20 )
=/
=

Longevity Biomedical's Current Ratio for the quarter that ended in . 20 is calculated as

Current Ratio (Q: . 20 )=Total Current Assets (Q: . 20 )/Total Current Liabilities (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.00 mean?
Longevity Biomedical (LBIO) has a Current Ratio of 0.00 as of . 20.
Is Longevity Biomedical's Current Ratio too high?
Longevity Biomedical's current Current Ratio is 0.00.
How does Longevity Biomedical's Current Ratio compare to ?
Longevity Biomedical's Current Ratio of 0.00 can be compared against companies in the Biotechnology industry. The industry median Current Ratio is 3.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.91, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Biomedical's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Current Ratio of 0.00. The current Current Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Current Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.